Platform|API|Archive|Contact

Humanexa SignalsPharmaceutical Intelligence

FDA
EMA
MHRA
PMDA
Health Canada

Phase I
Phase II
Phase III
Readouts
Enrollment Signals

Pipeline Tracking
Company Moves
Asset Intelligence
Landscape Reports

Pricing
Access
Commercial
Launch Tracking

Licensing
Acquisitions
Partnerships
Capital Raises

Strategy Catalysts Pricing

Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

Regulatory
Clinical
Competitive
Markets
M&A Watch
Strategy
Catalyst Tracker

Company

Pricing
Partner with us
Subscribe
Contact
Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Asset / Drug

Abiomed

Drug and asset intelligence for Abiomed with 10 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 5
Catalysts: 5
Stage: Development stage unavailable

Recent signals(5)

StrategyJuly 18, 2026

Abiomed recalls 14Fr Low Profile Introducer Kits due to thrombus risk

Abiomed has recalled its 14Fr Low Profile Introducer Kits due to the risk of thrombus formation with prolonged use.

RegulatoryJuly 3, 2026

Abiomed Recalls Impella CP Sets Due to Low Purge Pressure Risk

Abiomed has recalled specific Impella CP Sets due to out-of-specification conditions that may lead to low purge pressure events.

RegulatoryJune 29, 2026

Abiomed Issues Update on Automated Impella Controllers Due to Software Error

A software error may cause the Automated Impella Controller to restart when used with left ventricular Impella devices.

RegulatoryJune 22, 2026

Abiomed Issues Correction for Automated Impella Controllers Due to Safety Concerns

Abiomed has announced that certain Automated Impella Controllers require hardware updates to mitigate potential safety risks.

RegulatoryJune 19, 2026

Abiomed and Oscor Warn of Catheter Introducer Leakage Risk

Abiomed and Oscor reported a potential leakage issue in their introducer sheaths that may lead to increased access-site bleeding.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts(5)

Topline Data

— Abiomed

July 18, 2026 · N/A

Topline Data

— Abiomed

July 3, 2026 · N/A

Topline Data

— Abiomed

June 29, 2026 · N/A

Topline Data

— Abiomed

June 22, 2026 · N/A

Topline Data

— Abiomed

June 19, 2026 · N/A

Indications

No related entities indexed yet.

Therapeutic areas

Cardiology · Heart Pump →

Cardiology · Heart Pump Devices →

Cardiovascular →

Cardiovascular · Medical Devices →

Heart Pump Devices →

Medical Devices →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.